Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
World Journal of Gastrointestinal Oncology|February 16, 2026
Risk prediction for chronic atrophic gastritis using a random forest model: A multicenter studyHui Cao, Jing-Lue Han, Hao Wu, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|October 14, 2025
Helicobacter pylori Promoted miR-196a/b-5p Expression and Accelerated Tumorigenesis of the Gastric Mucosa by Targeting IGF2BP1 and Activating PI3K-Akt Signaling PathwayKe Chen, Jia-Wei Chen, Yao Shen, et al.
Frontiers in Pharmacology|April 8, 2025
Efficacy and cost-effectiveness analysis of 10-day versus 14-day eradication of Helicobacter pylori infection with vonoprazan amoxicillin: a prospective, multicenter, randomized controlled trialYunfan Dong, Zhaotao Duan, Min Liu, et al.
Molecular Carcinogenesis|December 4, 2024
Plasma Metabolomic Signatures of H. pylori Infection, Alcohol Drinking, Smoking, and Risk of Gastric CancerYuhui Yu, Zhonghua Zheng, Xinxiang Gao, et al.
Frontiers in Cellular and Infection Microbiology|May 13, 2025
Clinical evaluation of personalized Helicobacter pylori treatment guided by PCR detection from fecal samples: a real-world studyRuolin Peng, Zhimei Zhang, Chuchu Yang, et al.
Science China. Life Sciences|January 3, 2025
Altered 3D genome reorganization mediates precocious myeloid differentiation of aged hematopoietic stem cells in inflammationXinyu Cui, Yu Dong, Qiang Zhan, et al.
The Lancet. Gastroenterology & Hepatology|October 3, 2025
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 studyKaichun Wu, Changqing Zheng, Qian Cao, et al.
Journal of Gastroenterology and Hepatology|September 7, 2022
Efficacy of keverprazan for duodenal ulcer: A phase II randomized, double-blind, parallel-controlled trialNian-di Tan, Xiao-Wei Liu, Cheng-Xia Liu, et al.
Pageof 14